UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

Journal of rheumatology, 2019-02, Vol.46 (2), p.190

2019

Volltextzugriff (PDF)

Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis

The New England journal of medicine, 2017-04, Vol.376 (17), p.1637-1646

2017

Volltextzugriff (PDF)

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative

Rheumatology (Oxford, England), 2019-09, Vol.58 (9), p.1607-1616

2019

Volltextzugriff (PDF)

Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis

American journal of physiology. Renal physiology, 2018-12, Vol.315 (6), p.F1683-F1694

2018

Volltextzugriff (PDF)

Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches

Pediatric rheumatology online journal, 2021-08, Vol.19 (1), p.135-135, Article 135

2021

Volltextzugriff (PDF)

A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy

BMC nephrology, 2020-06, Vol.21 (1), p.1-245, Article 245

2020

Volltextzugriff (PDF)

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative

Rheumatology (Oxford, England), 2019-04, Vol.58 (4), p.672-682

2019

Volltextzugriff (PDF)

European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative

Annals of the rheumatic diseases, 2017-12, Vol.76 (12), p.1965

2017

Volltextzugriff (PDF)

Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases

International journal of molecular sciences, 2023-11, Vol.24 (22), p.16040

2023

Volltextzugriff (PDF)

A novel dried blood spot-LCMS method for the quantification of methotrexate polyglutamates as a potential marker for methotrexate use in children

PloS one, 2014-02, Vol.9 (2), p.e89908

2014

Volltextzugriff (PDF)

Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus

Journal of inflammation (London, England), 2019-11, Vol.16 (1), p.22-22, Article 22

2019

Volltextzugriff (PDF)

Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series

Clinical and experimental rheumatology, 2023-09, Vol.41 (9), p.1934

2023

Volltextzugriff (PDF)

Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners

PloS one, 2011-07, Vol.6 (7), p.e21604-e21604

2011

Volltextzugriff (PDF)

Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT

Health technology assessment (Winchester, England), 2019-04, Vol.23 (15), p.1-140

2019

Volltextzugriff (PDF)

Reporting involvement activities with children and young people in paediatric research: a framework analysis

Research involvement and engagement, 2023-07, Vol.9 (1), p.61-61, Article 61

2023

Volltextzugriff (PDF)

Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study

Health technology assessment (Winchester, England), 2020-07, Vol.24 (36), p.1-152

2020

Volltextzugriff (PDF)

Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa

PloS one, 2015-03, Vol.10 (3), p.e0120981

2015

Volltextzugriff (PDF)

Kidney outcomes for children with lupus nephritis

Pediatric nephrology (Berlin, West), 2021-06, Vol.36 (6), p.1377-1385

2021

Volltextzugriff (PDF)

Juvenile Idiopathic Arthritis Associated Uveitis

Children (Basel), 2021-07, Vol.8 (8), p.646

2021

Volltextzugriff (PDF)

Henoch schonlein purpura--a 5-year review and proposed pathway

PloS one, 2012-01, Vol.7 (1), p.e29512-e29512

2012

Volltextzugriff (PDF)

What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?

Frontiers in pediatrics, 2022-04, Vol.10, p.884634-884634

2022

Volltextzugriff (PDF)

Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus

Pediatric rheumatology online journal, 2015-04, Vol.13 (1), p.10-10, Article 10

2015

Volltextzugriff (PDF)

The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial

EClinicalMedicine, 2019-07, Vol.12, p.79-87

2019

Volltextzugriff (PDF)

European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative

Annals of the rheumatic diseases, 2017-11, Vol.76 (11), p.1788

2017

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(205)
Mit Volltextzugriff
(199)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(218)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus

Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis—the SHARE initiative

Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis

Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches

A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative

European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative

Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases

A novel dried blood spot-LCMS method for the quantification of methotrexate polyglutamates as a potential marker for methotrexate use in children

Mesangial cells are key contributors to the fibrotic damage seen in the lupus nephritis glomerulus

Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series

Communication about children's clinical trials as observed and experienced: qualitative study of parents and practitioners

Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis: a RCT

Reporting involvement activities with children and young people in paediatric research: a framework analysis

Different corticosteroid induction regimens in children and young people with juvenile idiopathic arthritis: the SIRJIA mixed-methods feasibility study

Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa

Kidney outcomes for children with lupus nephritis

Juvenile Idiopathic Arthritis Associated Uveitis

Henoch schonlein purpura--a 5-year review and proposed pathway

What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?

Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus

The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial

Treating juvenile idiopathic arthritis to target: recommendations of an international task force

European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative

Suchergebnisse filtern